Nicolas Hoertel, Katayoun Rezaei, Marina Sánchez-Rico, Alfonso Delgado-Álvarez, Johannes Kornhuber, Erich Gulbins, . . . on behalf of the AP-HP/Université Paris Cité/INSERM. (2023). Medications Modulating the Acid Sphingomyelinase/Ceramide System and 28-Day Mortality among Patients with SARS-CoV-2: An Observational Study. MDPI AG.
Chicago Style (17th ed.) CitationNicolas Hoertel, et al. Medications Modulating the Acid Sphingomyelinase/Ceramide System and 28-Day Mortality Among Patients with SARS-CoV-2: An Observational Study. MDPI AG, 2023.
MLA (9th ed.) CitationNicolas Hoertel, et al. Medications Modulating the Acid Sphingomyelinase/Ceramide System and 28-Day Mortality Among Patients with SARS-CoV-2: An Observational Study. MDPI AG, 2023.
Warning: These citations may not always be 100% accurate.